Siga Technologies Inc.

SIGA Healthcare Drug Manufacturers Specialty & Generic

Siga Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $94.6 million, down 31.8% from fiscal 2024. In the quarter to June 2026, revenue fell 49.5%, EPS fell 66.0% and free cash flow fell 76.0%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

3.17 0.02 −0.63%
Market cap
$229.2M
P/E
0.0×
Fwd P/E
28.7×
Dividend yield
0.00%
F-score
5/9
Altman Z
14.28
Beneish M
−4.02
Dividend safety
36/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
38.84 30.56 112.10 160.99 117.89 103.14 98.79 150.15 155.40 154.97
Receivables
3.15 1.80 1.96 4.17 3.34 83.65 45.41 21.13 21.17 3.26
Inventory
26.21 2.98 2.91 9.65 20.27 19.51 39.27 64.22 49.56 49.05
Total current assets
69.16 37.36 121.29 180.04 143.61 208.75 185.79 238.99 231.04 212.86
Property, Plant, Equpment (Net)
0.30 0.14 0.17 2.62 2.10 2.37 1.85 1.33 1.30 1.09
Goodwill and Intangible Assets (Total)
0.90 0.90 0.90 0.90 0.90 0.90 0.90 0.90 0.90 0.90
Long Term Assets (Tax, Deferred)
— 2.43 11.73 14.15 2.54 2.42 6.25 11.05 10.85 4.43
Long-term assets (Other)
17.98 7.24 69.35 0.86 0.68 0.29 0.25 2.08 0.24 0.19
Total non-current assets
91.82 107.31 82.15 18.52 6.22 5.97 9.25 15.36 13.29 6.61
Total Assets
160.98 144.67 203.44 198.57 149.83 214.73 195.04 254.35 244.34 219.47
Accounts Payable
2.52 1.33 1.69 3.05 1.28 2.03 3.36 1.46 1.34 0.82
Accrued Expenses
4.58 5.48 9.65 8.64 8.29 9.25 6.30 10.18 5.64 6.52
Current Part of Debt
— — — 80.04 — — — — — —
Current Part of Taxes to Pay
— — — — 0.92 19.21 1.31 21.69 8.02 0.41
Current Revenue (Deferred)
— — — — — — 10.55 20.79 10.33 10.24
Total current liabilities
7.10 6.81 11.34 91.74 10.48 30.49 21.52 54.12 25.33 17.99
Long Term Debt (Total)
66.55 71.05 75.55 — — — — — — —
Non-current Revenue (Deferred)
367.48 377.64 — — — — — — — —
Long Term Tax Liability (Deferred)
0.29 — — — — — — — — —
Non-current Liabilities (Other)
6.98 12.31 13.64 9.05 9.55 9.92 3.36 3.38 3.20 2.65
Total non-current liabilities
441.30 461.00 89.19 9.05 9.55 9.92 3.36 3.38 3.20 2.65
Total liabilities
448.40 467.81 100.53 100.78 20.04 40.41 24.88 57.49 28.53 20.65
Additional Paid In Capital
213.71 214.23 218.70 220.81 224.98 226.07 233.96 235.80 238.64 241.89
Common Stock (Net)
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Retained Earnings
(501.14) (537.38) (115.79) (123.03) (95.19) (51.76) (63.80) (38.94) (22.84) (43.07)
Common Equity (Total)
(287.42) (323.14) 102.91 97.78 129.79 174.31 170.16 196.86 215.80 198.82
Shareholders Equity (Total)
(287.42) (323.14) 102.91 97.78 129.79 174.31 170.16 196.86 215.80 198.82
Shareholders Equity and Liabilities (Total)
160.98 144.67 203.44 198.57 149.83 214.73 195.04 254.35 244.34 219.47
Shares (Common)
78.69 79.04 80.76 81.27 77.20 73.54 72.68 71.09 71.41 71.61
Shareholders Equity (Tangible)
(288.32) (324.04) 102.02 96.89 128.89 173.42 169.26 195.96 214.91 197.92
Net Debt
27.71 40.49 (36.56) (80.94) (117.89) (103.14) (98.79) (150.15) (155.40) (154.97)
Total Debt
66.55 71.05 75.55 80.04 2.35 2.57 2.03 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates